NuCana plc (NCNA)

NASDAQ

$1.31

NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.

Website: https://www.nucana.com

Sector:

Healthcare

Industry:

Biotechnology

Target: $104 (+7838.93%)

Market Cap

$4.99M

P/B Ratio

0.19

Price Chart

Adjust inflation

Log

Valuation

Market Cap$4.99M

P/B0.19

Profitability

EBITDA-$30M

EPS-$7.83

Financial Health

Debt-to-Equity3%

Growth & Risk

EPS 5Y CAGR-7.02%

FCF 5Y CAGR-21.10%

Sharpe Ratio-1.43